The purpose of this study was to describe metabolic changes in the first 16 weeks of
anti-psychotic treatment in previously drug-naïve patients with psychosis.
We hypothesize that in drug-naive patients, greater insulin resistance prior to treatment
predicts a disproportionately greater increase in insulin resistance with olanzapine
treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)